InvestorsHub Logo
Followers 22
Posts 3629
Boards Moderated 0
Alias Born 07/20/2006

Re: rwwine post# 1769

Wednesday, 02/17/2021 5:55:20 PM

Wednesday, February 17, 2021 5:55:20 PM

Post# of 7067

Conversely....possible delay


If that was valid, a press release would be forthcoming. No CRL - NO
delay.

Furthermore, review this KEY paragraph that I previously posted:

We manufacture our primary drug candidate, DaxibotulinumtoxinA
for Injection. This neuromodulator is a proprietary formulation of
botulinum toxin A, deemed a Tier 1 Select Agent by the Centers for
Disease Control and Prevention (CDC). Thus, our research, development and manufacturing operations are highly regulated. Our operations are regularly inspected by the U.S. Food and Drug Administration (FDA),the U.S. Department of Homeland Security and the Centers for Disease Control and Prevention. Due to the nature of DaxibotulinumtoxinA, and the required regulatory oversight, there is a great deal of social and scientific responsibility on the company. We take that responsibility extremely seriously as evidenced by our policies, procedures, and operations. And the company is audited by local, state and federal agencies, and we have met or exceeded all safety and environmental standards on an annual basis to ensure proper safety measures exist.

https://www.revance.com/wp-content/uploads/RVNC-ESG-Report-2020_final.pdf

Regards,

FLO
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RVNC News